Proteome Sciences (PRM) Competitors GBX 2.74 0.00 (0.00%) As of 05/1/2025 07:44 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock PRM vs. VGAS, ALB, ADES, LOOP, PPG, REX, SMG, PCT, SLI, and LTHMShould you be buying Proteome Sciences stock or one of its competitors? The main competitors of Proteome Sciences include Volga Gas (VGAS), Albert Technologies (ALB), ADES International (ADES), LoopUp Group (LOOP), Plutus PowerGen (PPG), 3260041 (REX.L) (REX), 646143 (SMG.L) (SMG), Polar Capital Technology Trust (PCT), Standard Life Investments Property Income Trust (SLI), and James Latham (LTHM). These companies are all part of the "chemicals" industry. Proteome Sciences vs. Volga Gas Albert Technologies ADES International LoopUp Group Plutus PowerGen 3260041 (REX.L) 646143 (SMG.L) Polar Capital Technology Trust Standard Life Investments Property Income Trust James Latham Proteome Sciences (LON:PRM) and Volga Gas (LON:VGAS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Is PRM or VGAS more profitable? Volga Gas has a net margin of 0.00% compared to Proteome Sciences' net margin of -0.04%. Volga Gas' return on equity of 0.00% beat Proteome Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Proteome Sciences-0.04% -0.01% -19.25% Volga Gas N/A N/A N/A Does the media refer more to PRM or VGAS? In the previous week, Proteome Sciences' average media sentiment score of 0.00 equaled Volga Gas'average media sentiment score. Company Overall Sentiment Proteome Sciences Neutral Volga Gas Neutral Do institutionals & insiders hold more shares of PRM or VGAS? 23.0% of Proteome Sciences shares are held by institutional investors. 19.5% of Proteome Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor PRM or VGAS? Proteome Sciences received 72 more outperform votes than Volga Gas when rated by MarketBeat users. However, 73.77% of users gave Volga Gas an outperform vote while only 57.04% of users gave Proteome Sciences an outperform vote. CompanyUnderperformOutperformProteome SciencesOutperform Votes16257.04% Underperform Votes12242.96% Volga GasOutperform Votes9073.77% Underperform Votes3226.23% Which has stronger valuation & earnings, PRM or VGAS? Volga Gas has lower revenue, but higher earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Volga Gas, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProteome Sciences£10.88B0.00-£4.08M-£1.38-1.98Volga Gas£18.73M0.00N/A-£19.20N/A SummaryProteome Sciences and Volga Gas tied by winning 5 of the 10 factors compared between the two stocks. Get Proteome Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart PRM vs. The Competition Export to ExcelMetricProteome SciencesDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£8.09M£788.79M£5.54B£2.58BDividend Yield6.17%5.44%5.09%4.97%P/E Ratio-1.981.9122.58130.65Price / Sales0.00445.91401.13232,189.14Price / Cash3.7311.4238.1828.14Price / Book-1.542.736.774.60Net Income-£4.08M£308.37B£3.22B£5.84B7 Day Performance-13.84%-1.82%1.10%3.01%1 Month Performance-34.76%0.88%2.49%10.14%1 Year Performance-21.94%-8.31%15.76%117.30% Proteome Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRMProteome SciencesN/AGBX 2.74flatN/A-21.9%£8.09M£10.88B-1.98240Gap DownVGASVolga GasN/AN/AN/AN/A£18.99M£18.73M-1.222ALBAlbert TechnologiesN/AN/AN/AN/A£7.98M£4.61M-0.537,400Gap UpHigh Trading VolumeADESADES InternationalN/AN/AN/AN/A£5.09M£452.11M26.62140LOOPLoopUp GroupN/AN/AN/AN/A£1.43M£22.07M-5.8390PPGPlutus PowerGenN/AN/AN/AN/A£1.32M£1.17M-0.1952,000REX3260041 (REX.L)N/AN/AN/AN/A£0.00N/A0.00120SMG646143 (SMG.L)N/AN/AN/AN/A£0.00N/A0.006,100High Trading VolumePCTPolar Capital Technology TrustN/AGBX 291.20+0.4%N/A-89.5%£3.43B£1.24B2.86120News CoveragePositive NewsGap UpSLIStandard Life Investments Property Income TrustN/AN/AN/AN/A£312.43M£29.95M3.672,021LTHMJames LathamN/AGBX 1,044+1.9%N/A-12.5%£206.23M£359.76M9.191,350Dividend Cut Related Companies and Tools Related Companies Volga Gas Competitors Albert Technologies Competitors ADES International Competitors LoopUp Group Competitors Plutus PowerGen Competitors 3260041 (REX.L) Competitors 646143 (SMG.L) Competitors Polar Capital Technology Trust Competitors Standard Life Investments Property Income Trust Competitors James Latham Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PRM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteome Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRM Stock Free PRM Stock Alerts